_id
69105c67ccc777a4e85d585a
Ticker
DOSEF
Name
Doseology Sciences Inc.
Exchange
OTCQB
Address
9-3151 Lakeshore Road, Kelowna, BC, Canada, V1W 3S9
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://doseology.com
Description
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Last Close
0.0516
Volume
320
Current Price
0.4777
Change
0
Last Updated
2026-01-02T12:45:20.848Z
Image
data:image/webp;base64,UklGRiwBAABXRUJQVlA4ICABAABQCQCdASpAAEAAPrFKoEmnJKMhLBVeYOAWCWkACB2LZNYb1fGyR2Ex/ODdCkYxFI1YnGhlgIerySP6fRSTkJqlYd2BJjvQn0aCZmTeAZWEqPIAAAD++bFteofOhnmbBWaP9dVWzLPC4IqPcffdpPw14M7KuwRdgrYrFPU7lmxfjwTMOaD49z1qOGBWyDGY4GJL3UeZLAm9DPxOZpx7JP/0aLg7u+HwJJrdxd29Ugd/Y5dB0GGC7y4qAfaXr0lbI9NVvEOYqR5D642X18RV6UZxL5MraekJGS+bPwWlF/SLQjQx/H5wZn+vNzUDkZoGjxC3eSCgQtIbDVLVwM/JajrQJsLI5nIsHe5SDhDgYMooVE2+Q02c1vaO6LZMKUURYAA=
Ipo Date
-
Market Cap
2804067
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
4927
Cost Of Revenue
1461
Gross Profit
3466
Operating Expenses
184767
Operating Income
-179840
Interest Expense
-
Pretax Income
-171913
Net Income
-171911
Eps
-0.021457705001272528
Dividends Per Share
-
Shares Outstanding
8011621
Income Tax Expense
-
EBITDA
-
Operating Margin
-3650.0913334686425
Total Other Income Expense Net
-
Cash
1323962
Short Term Investments
-
Receivables
3753
Inventories
69330
Total Current Assets
1446281
Property Plant Equipment
-
Total Assets
1793281
Payables
39008
Short Term Debt
-
Long Term Debt
-
Total Liabilities
107033
Equity
1686248
Bs_currency_symbol
CAD
Depreciation
-
Change In Working Capital
5719
Cash From Operations
-105698
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-105698
Cf_currency_symbol
CAD
PE
-
PB
2.2696254357010357
ROE
-10.194882366057662
ROA
-9.586394993311142
FCF
-105698
Fcf Percent
-21.452811041201542
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
5.5
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
6
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
4927
Quarters > 0 > income Statement > cost Of Revenue
1461
Quarters > 0 > income Statement > gross Profit
3466
Quarters > 0 > income Statement > operating Expenses
184767
Quarters > 0 > income Statement > operating Income
-179840
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-171913
Quarters > 0 > income Statement > net Income
-171911
Quarters > 0 > income Statement > eps
-0.021457705001272528
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
8011621
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-3650.0913334686425
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
1323962
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
3753
Quarters > 0 > balance Sheet > inventories
69330
Quarters > 0 > balance Sheet > total Current Assets
1446281
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
1793281
Quarters > 0 > balance Sheet > payables
39008
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
107033
Quarters > 0 > balance Sheet > equity
1686248
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-171911
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
5719
Quarters > 0 > cash Flow > cash From Operations
-105698
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-105698
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.021457705001272528
Quarters > 0 > ratios > PB
2.2696254357010357
Quarters > 0 > ratios > ROE
-10.194882366057662
Quarters > 0 > ratios > ROA
-9.586394993311142
Quarters > 0 > ratios > FCF
-105698
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-21.452811041201542
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1107
Quarters > 1 > income Statement > cost Of Revenue
720
Quarters > 1 > income Statement > gross Profit
387
Quarters > 1 > income Statement > operating Expenses
244220
Quarters > 1 > income Statement > operating Income
-243113
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-239697
Quarters > 1 > income Statement > net Income
-239697
Quarters > 1 > income Statement > eps
-0.030586740654242876
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
7836631
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-21961.427280939475
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
1429660
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
22905
Quarters > 1 > balance Sheet > inventories
17037
Quarters > 1 > balance Sheet > total Current Assets
1491770
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
1491770
Quarters > 1 > balance Sheet > payables
44235
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
94105
Quarters > 1 > balance Sheet > equity
1397665
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-239697
Quarters > 1 > cash Flow > depreciation
0
Quarters > 1 > cash Flow > change In Working Capital
53933
Quarters > 1 > cash Flow > cash From Operations
-101791
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
609886
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.030586740654242876
Quarters > 1 > ratios > PB
2.678437700521942
Quarters > 1 > ratios > ROE
-17.149817731716826
Quarters > 1 > ratios > ROA
-16.067959537998487
Quarters > 1 > ratios > FCF
-101791
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-91.95212285456188
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
22267
Quarters > 2 > income Statement > cost Of Revenue
13360
Quarters > 2 > income Statement > gross Profit
8907
Quarters > 2 > income Statement > operating Expenses
104344
Quarters > 2 > income Statement > operating Income
-82077
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-77409
Quarters > 2 > income Statement > net Income
-77409
Quarters > 2 > income Statement > eps
-0.01719999333411102
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4500525
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-368.6037634167153
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
819774
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
28906
Quarters > 2 > balance Sheet > inventories
17037
Quarters > 2 > balance Sheet > total Current Assets
871609
Quarters > 2 > balance Sheet > property Plant Equipment
0
Quarters > 2 > balance Sheet > total Assets
871609
Quarters > 2 > balance Sheet > payables
10399
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
29899
Quarters > 2 > balance Sheet > equity
841710
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-77409
Quarters > 2 > cash Flow > depreciation
0
Quarters > 2 > cash Flow > change In Working Capital
-50484
Quarters > 2 > cash Flow > cash From Operations
-111393
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-111393
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.01719999333411102
Quarters > 2 > ratios > PB
2.5542060715685926
Quarters > 2 > ratios > ROE
-9.196635420750615
Quarters > 2 > ratios > ROA
-8.88116116286087
Quarters > 2 > ratios > FCF
-111393
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-5.002604751425877
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
4605
Quarters > 3 > income Statement > cost Of Revenue
2020
Quarters > 3 > income Statement > gross Profit
2585
Quarters > 3 > income Statement > operating Expenses
71368
Quarters > 3 > income Statement > operating Income
-66763
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-58409
Quarters > 3 > income Statement > net Income
-58409
Quarters > 3 > income Statement > eps
-0.013273188994494974
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
4400525
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-1449.7937024972857
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
931167
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
11004
Quarters > 3 > balance Sheet > inventories
30397
Quarters > 3 > balance Sheet > total Current Assets
978158
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
978158
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
75539
Quarters > 3 > balance Sheet > equity
902619
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-58409
Quarters > 3 > cash Flow > depreciation
0
Quarters > 3 > cash Flow > change In Working Capital
-838
Quarters > 3 > cash Flow > cash From Operations
-59247
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-59247
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.013273188994494974
Quarters > 3 > ratios > PB
2.328923712552029
Quarters > 3 > ratios > ROE
-6.471058109789402
Quarters > 3 > ratios > ROA
-5.971325695848728
Quarters > 3 > ratios > FCF
-59247
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-12.865798045602606
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
42556
Annuals > 0 > income Statement > cost Of Revenue
23671
Annuals > 0 > income Statement > gross Profit
18885
Annuals > 0 > income Statement > operating Expenses
514162
Annuals > 0 > income Statement > operating Income
-471606
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-447788
Annuals > 0 > income Statement > net Income
-447788
Annuals > 0 > income Statement > eps
-0.057140370651623126
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
7836631
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-1108.2009587367234
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
1429660
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
22905
Annuals > 0 > balance Sheet > inventories
17037
Annuals > 0 > balance Sheet > total Current Assets
1491770
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
1491770
Annuals > 0 > balance Sheet > payables
44235
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
94105
Annuals > 0 > balance Sheet > equity
1397665
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-447788
Annuals > 0 > cash Flow > depreciation
0
Annuals > 0 > cash Flow > change In Working Capital
-8488
Annuals > 0 > cash Flow > cash From Operations
-342239
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
711677
Annuals > 0 > cash Flow > net Change In Cash
369438
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.057140370651623126
Annuals > 0 > ratios > PB
1.9624308042342047
Annuals > 0 > ratios > ROE
-32.03829243774438
Annuals > 0 > ratios > ROA
-30.0172278568412
Annuals > 0 > ratios > FCF
-342239
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-8.042085722342325
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
98522
Annuals > 1 > income Statement > cost Of Revenue
26435
Annuals > 1 > income Statement > gross Profit
72087
Annuals > 1 > income Statement > operating Expenses
476155
Annuals > 1 > income Statement > operating Income
-377633
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-339848
Annuals > 1 > income Statement > net Income
-339848
Annuals > 1 > income Statement > eps
-0.07722896699825589
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
4400525
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-383.29814660684923
Annuals > 1 > income Statement > total Other Income Expense Net
8495
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
1060222
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
2304
Annuals > 1 > balance Sheet > inventories
39705
Annuals > 1 > balance Sheet > total Current Assets
1102231
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
1102231
Annuals > 1 > balance Sheet > payables
47098
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
82493
Annuals > 1 > balance Sheet > equity
1019738
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-339848
Annuals > 1 > cash Flow > depreciation
20370
Annuals > 1 > cash Flow > change In Working Capital
32924
Annuals > 1 > cash Flow > cash From Operations
-235118
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-6138
Annuals > 1 > cash Flow > net Change In Cash
-241256
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.07722896699825589
Annuals > 1 > ratios > PB
1.510372026932408
Annuals > 1 > ratios > ROE
-33.326991835157656
Annuals > 1 > ratios > ROA
-30.832738327991137
Annuals > 1 > ratios > FCF
-235118
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.386451756967987
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
43088
Annuals > 2 > income Statement > cost Of Revenue
1802
Annuals > 2 > income Statement > gross Profit
41286
Annuals > 2 > income Statement > operating Expenses
873459
Annuals > 2 > income Statement > operating Income
-767133
Annuals > 2 > income Statement > interest Expense
36136
Annuals > 2 > income Statement > pretax Income
-1781544
Annuals > 2 > income Statement > net Income
-1781544
Annuals > 2 > income Statement > eps
-0.04334625294705878
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
41100300
Annuals > 2 > income Statement > income Tax Expense
36136
Annuals > 2 > income Statement > EBITDA
-701040
Annuals > 2 > income Statement > operating Margin
-1780.3866505755664
Annuals > 2 > income Statement > total Other Income Expense Net
-978275
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
1301478
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
17100
Annuals > 2 > balance Sheet > inventories
8591
Annuals > 2 > balance Sheet > total Current Assets
1342838
Annuals > 2 > balance Sheet > property Plant Equipment
56008
Annuals > 2 > balance Sheet > total Assets
1398846
Annuals > 2 > balance Sheet > payables
20918
Annuals > 2 > balance Sheet > short Term Debt
42684
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
99190
Annuals > 2 > balance Sheet > equity
1299656
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-1781544
Annuals > 2 > cash Flow > depreciation
66093
Annuals > 2 > cash Flow > change In Working Capital
136582
Annuals > 2 > cash Flow > cash From Operations
-481054
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-91884
Annuals > 2 > cash Flow > net Change In Cash
-572938
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.04334625294705878
Annuals > 2 > ratios > PB
11.068394252017457
Annuals > 2 > ratios > ROE
-137.0781191330629
Annuals > 2 > ratios > ROA
-127.35812233798431
Annuals > 2 > ratios > FCF
-481054
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-11.164454140363906
Annuals > 2 > health Score
27
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
16048
Annuals > 3 > income Statement > cost Of Revenue
164427
Annuals > 3 > income Statement > gross Profit
-148379
Annuals > 3 > income Statement > operating Expenses
1668263
Annuals > 3 > income Statement > operating Income
-1809806
Annuals > 3 > income Statement > interest Expense
75774
Annuals > 3 > income Statement > pretax Income
-1939321
Annuals > 3 > income Statement > net Income
-1939321
Annuals > 3 > income Statement > eps
-0.04960271958998462
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
39097070
Annuals > 3 > income Statement > income Tax Expense
75774
Annuals > 3 > income Statement > EBITDA
-1670272
Annuals > 3 > income Statement > operating Margin
-11277.455134596212
Annuals > 3 > income Statement > total Other Income Expense Net
-53741
Annuals > 3 > income Statement > currency_symbol
CAD
Annuals > 3 > balance Sheet > cash
1874416
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
85412
Annuals > 3 > balance Sheet > inventories
10393
Annuals > 3 > balance Sheet > total Current Assets
2972513
Annuals > 3 > balance Sheet > property Plant Equipment
882828
Annuals > 3 > balance Sheet > total Assets
3869305
Annuals > 3 > balance Sheet > payables
90739
Annuals > 3 > balance Sheet > short Term Debt
93460
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
871509
Annuals > 3 > balance Sheet > equity
2997796
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-1939321
Annuals > 3 > cash Flow > depreciation
139534
Annuals > 3 > cash Flow > change In Working Capital
-284270
Annuals > 3 > cash Flow > cash From Operations
-1711154
Annuals > 3 > cash Flow > capital Expenditures
7875
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-140079
Annuals > 3 > cash Flow > net Change In Cash
-1859108
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-0.04960271958998462
Annuals > 3 > ratios > PB
4.564678350361398
Annuals > 3 > ratios > ROE
-64.69156006612859
Annuals > 3 > ratios > ROA
-50.12065474290603
Annuals > 3 > ratios > FCF
-1719029
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-107.11795862412762
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.021457705001272528
Valuation > metrics > PB
2.2696254357010357
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-10.194882366057662
Profitability > metrics > ROA
-11.886417646363327
Profitability > metrics > Net Margin
-34.89161761721128
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.063474056010741
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
37.07652276456112
Liquidity > metrics > Quick Ratio
35.299195036915506
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
80
Prev Risks > 1
80
Prev Risks > 2
80
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
50
Updated At
2026-01-20T21:43:31.877Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0156
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0361
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0116
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.009
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-0.0124
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.0182
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.0065
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.0186
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.0142
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.207
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.0199
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2022-12-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.0337
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-09-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.0633
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-06-30
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.1044
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATHE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point The Manila Times
Read more →Novo Nordisk’s Wegovy Weight Loss Pill Has a Strong Launch—and Other Reasons the Stock Is Rising Barron's
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Doseology Sciences Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0156
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.